Safety and Efficacy of Efavaleukin Alfa in Subjects With Active Rheumatoid Arthritis
Clinical trial NCT03410056 · TERMINATED
Trial details
- NCT number
- NCT03410056
- Sponsor
- Amgen
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-22
- Primary completion
- 2019-12-10
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.